Literature DB >> 19396530

Synthesis, characterization, DNA-binding and antiproliferative activity of Nd(III) complexes with N-(nitrogen heterocyclic) norcantharidin acylamide acid.

Wen-Zhong Zhu1, Qiu-Yue Lin, Mei Lu, Rui-Ding Hu, Xiao-Liang Zheng, Jian-Ping Cheng, Yun-Yun Wang.   

Abstract

Three novel complexes [Nd(L)(NO3)(H2O)2].NO(3).2H2O (HL1 = N-pyrimidine norcantharidin acylamide acid, C12H13N3O4; HL2 = N-pyridine norcantharidin acylamide acid, C13H14N2O4; HL3 = N-phenyl norcantharidin acylamide acid, C14H15NO4) were synthesized. HL1, HL2 and HL3 are the ligand of complex(1), complex(2) and complex(3), respectively. Their structures were characterized by elemental analysis, conductivity measurement, infrared spectra and thermogravimetric analysis. The DNA-binding properties of the complexes have been investigated by fluorescence spectroscopy and viscosity measurements. The results suggest that the complexes can bind to DNA by partial intercalation. The liner Stern-Volmer quenching constant Ksq values are 3.3(+/-0.21)(1), 1.7(+/-0.19)(2) and 0.9(+/-0.04)(3), respectively. Complex (1) and (2) have been found to cleave pBR322 plasmid DNA at physiological pH and temperature. The test of antiproliferation activity indicates that complex(1) has strong antiproliferative ability against the SMMC7721 (IC50 = 131.7 +/- 23.4 micromol x L(-1)) and A549 (IC50 = 128.4 +/- 19.9 micromol x L(-1)) cell lines. The inhibition rates of complex(2) (IC50 = 86.3 +/- 11.3 micromol x L(-1)) are much higher than that of NCTD (IC50 = 115.5 +/- 9.5 micromol x L(-1)) and HL2 (111.0 +/- 5.7 micromol x L(-1)) against SMMC7721 cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396530     DOI: 10.1007/s10895-009-0483-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  21 in total

1.  Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety.

Authors:  Y P Ho; K K To; S C Au-Yeung; X Wang; G Lin; X Han
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

2.  Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules.

Authors:  J R Lakowicz; G Weber
Journal:  Biochemistry       Date:  1973-10-09       Impact factor: 3.162

3.  Synthesis and DNA binding of mu-[2,9-bis(2-imidazo[4,5-f][1,10]phenanthroline)-1,10-phenanthroline]bis[1,10-phenanthrolinecopper(II)].

Authors:  Jian-Zhong Wu; Li Yuan; Jian-Fang Wu
Journal:  J Inorg Biochem       Date:  2005-09-19       Impact factor: 4.155

4.  Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.

Authors:  B C Baguley; M Le Bret
Journal:  Biochemistry       Date:  1984-02-28       Impact factor: 3.162

5.  A study of the interactions of some polypyridylruthenium (II) complexes with DNA using fluorescence spectroscopy, topoisomerisation and thermal denaturation.

Authors:  J M Kelly; A B Tossi; D J McConnell; C OhUigin
Journal:  Nucleic Acids Res       Date:  1985-09-11       Impact factor: 16.971

6.  Synthesis, characterization and DNA-binding studies of 2-carboxybenzaldehydeisonicotinoylhydrazone and its La(III), Sm(III) and Eu(III) complexes.

Authors:  Yuan Wang; Yan Wang; Zheng-Yin Yang
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2006-03-08       Impact factor: 4.098

7.  DNA-binding and cleavage studies of macrocyclic copper(II) complexes.

Authors:  Jie Liu; Tixiang Zhang; Tongbu Lu; Lianghu Qu; Hui Zhou; Qianling Zhang; Liangnian Ji
Journal:  J Inorg Biochem       Date:  2002-07-25       Impact factor: 4.155

8.  Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma.

Authors:  Huayu Yang; Wei Guo; Bo Xu; Min Li; Jingrong Cui
Journal:  Anticancer Drugs       Date:  2007-11       Impact factor: 2.248

9.  Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding.

Authors:  S Satyanarayana; J C Dabrowiak; J B Chaires
Journal:  Biochemistry       Date:  1993-03-16       Impact factor: 3.162

Review 10.  Medical uses of mylabris in ancient China and recent studies.

Authors:  G S Wang
Journal:  J Ethnopharmacol       Date:  1989-09       Impact factor: 4.360

View more
  2 in total

1.  Synthesis, crystal structure, interaction with BSA and antibacterial activity of La(III) and Sm(III) complexes with enrofloxacin.

Authors:  Yan-Jun Wang; Rui-Ding Hu; Dong-Hua Jiang; Ping-Hua Zhang; Qiu-Yue Lin; Yun-Yun Wang
Journal:  J Fluoresc       Date:  2010-12-03       Impact factor: 2.217

2.  Crystal structures, interactions with biomacromolecules and anticancer activities of Mn(II), Ni(II), Cu(II) complexes of demethylcantharate and 2-aminopyridine.

Authors:  Fan Zhang; Qiu-Yue Lin; Xiao-Liang Zheng; Ling-Ling Zhang; Qiong Yang; Jia-Ying Gu
Journal:  J Fluoresc       Date:  2012-06-26       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.